Author Correction: A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
20 Nov 2019
Historique:
entrez: 21 11 2019
pubmed: 21 11 2019
medline: 21 11 2019
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 31745085
doi: 10.1038/s41467-019-13379-9
pii: 10.1038/s41467-019-13379-9
pmc: PMC6864049
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

5337

Commentaires et corrections

Type : ErratumFor

Auteurs

S J Tavernier (SJ)

Primary Immune Deficiency Research Lab, Department of Internal Medicine and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
VIB Center for Inflammation Research, Unit of Molecular Signal Transduction in Inflammation, Ghent, Belgium.
Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.

V Athanasopoulos (V)

Department of Immunology and Infectious Disease and Center for Personalised Immunology (NHMRC Centre for Research Excellence), John Curtin School of Medical Research, Australian National University, Canberra, Australia.
Centre for Personalised Immunology (CACPI), Shanghai Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.

P Verloo (P)

Department of Internal Medicine and Pediatrics, Division of Pediatric Neurology and Metabolism, Ghent University Hospital, Ghent, Belgium.

G Behrens (G)

Institute for Immunology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Research Unit Molecular Immune Regulation, Helmholtz Zentrum München, Munich, Germany.

J Staal (J)

VIB Center for Inflammation Research, Unit of Molecular Signal Transduction in Inflammation, Ghent, Belgium.
Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.

D J Bogaert (DJ)

Primary Immune Deficiency Research Lab, Department of Internal Medicine and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Department of Internal Medicine and Pediatrics, Division of Pediatric Immunology and Pulmonology, Ghent University Hospital, Ghent, Belgium.

L Naesens (L)

Primary Immune Deficiency Research Lab, Department of Internal Medicine and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.

M De Bruyne (M)

Primary Immune Deficiency Research Lab, Department of Internal Medicine and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

S Van Gassen (S)

VIB Center for Inflammation Research, Unit of Data Mining and Modeling for Biomedicine, Ghent, Belgium.
Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Gent, Belgium.

E Parthoens (E)

VIB Bioimaging Core, VIB Center for Inflammation Research, Ghent, Belgium.

J Ellyard (J)

Department of Immunology and Infectious Disease and Center for Personalised Immunology (NHMRC Centre for Research Excellence), John Curtin School of Medical Research, Australian National University, Canberra, Australia.

J Cappello (J)

Department of Immunology and Infectious Disease and Center for Personalised Immunology (NHMRC Centre for Research Excellence), John Curtin School of Medical Research, Australian National University, Canberra, Australia.

L X Morris (LX)

The Australian Phenomics Facility, John Curtin School of Medical Research, Australian National University, Canberra, Australia.

H Van Gorp (H)

Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.
VIB Center for Inflammation Research, Ghent, Belgium.

G Van Isterdael (G)

Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
VIB Flow Core, VIB Center for Inflammation Research, Ghent, Belgium.

Y Saeys (Y)

VIB Center for Inflammation Research, Unit of Data Mining and Modeling for Biomedicine, Ghent, Belgium.
Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Gent, Belgium.

M Lamkanfi (M)

Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.
VIB Center for Inflammation Research, Ghent, Belgium.

P Schelstraete (P)

Department of Internal Medicine and Pediatrics, Division of Pediatric Immunology and Pulmonology, Ghent University Hospital, Ghent, Belgium.

J Dehoorne (J)

Department of Internal Medicine and Pediatrics, Division of Pediatric Rheumatology, Ghent University Hospital, Ghent, Belgium.

V Bordon (V)

Department of Internal Medicine and Pediatrics, Division of Pediatric Immunology and Pulmonology, Ghent University Hospital, Ghent, Belgium.

R Van Coster (R)

Department of Internal Medicine and Pediatrics, Division of Pediatric Neurology and Metabolism, Ghent University Hospital, Ghent, Belgium.

B N Lambrecht (BN)

Department of Internal Medicine and Pediatrics, Division of Pulmonology, Ghent University Hospital, Ghent, Belgium.
VIB Center for Inflammation Research, Unit for Immunoregulation and Mucosal Immunology, Ghent, Belgium.
Department of Pulmonary Medicine, ErasmusMC, Rotterdam, The Netherlands.

B Menten (B)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

R Beyaert (R)

VIB Center for Inflammation Research, Unit of Molecular Signal Transduction in Inflammation, Ghent, Belgium.
Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.

C G Vinuesa (CG)

Department of Immunology and Infectious Disease and Center for Personalised Immunology (NHMRC Centre for Research Excellence), John Curtin School of Medical Research, Australian National University, Canberra, Australia.
Centre for Personalised Immunology (CACPI), Shanghai Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.

V Heissmeyer (V)

Institute for Immunology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Research Unit Molecular Immune Regulation, Helmholtz Zentrum München, Munich, Germany.

M Dullaers (M)

Primary Immune Deficiency Research Lab, Department of Internal Medicine and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Ablynx, a Sanofi Company, Zwijnaarde, Belgium.

F Haerynck (F)

Primary Immune Deficiency Research Lab, Department of Internal Medicine and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium. Filomeen.Haerynck@ugent.be.
Department of Internal Medicine and Pediatrics, Division of Pediatric Immunology and Pulmonology, Ghent University Hospital, Ghent, Belgium. Filomeen.Haerynck@ugent.be.

Classifications MeSH